Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MREO Mereo Biopharma Group Plc

Pre-Mkt 01-13 08:03:16 EST

0.5673

+0.0729

+14.75%

盘前0.5460

-0.0213-3.75%

08:03 EST

High0.6800	Low0.5193	Vol53.33M
Open0.5660	D1 Closing0.4944	Amplitude32.50%
Mkt Cap90.28M	Tradable Cap57.00M	Total Shares159.13M
T/O31.54M	T/O Rate53.08%	Tradable Shares100.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":0.5673,"timestamp":1768251600000,"preClose":0.4944,"halted":0,"volume":53334466,"hourTrading":{"tag":"盘前","latestPrice":0.546,"preClose":0.5673,"latestTime":"08:03 EST","volume":209682,"amount":114712.618878,"timestamp":1768309381845},"delay":0,"floatShares":100470459,"shares":159131700,"eps":-0.261249,"marketStatus":"Pre-Mkt","change":0.0729,"latestTime":"01-13 08:03:16 EST","open":0.566,"high":0.68,"low":0.5193,"amount":31538405.782668296,"amplitude":0.32504,"askPrice":0.5777,"askSize":237,"bidPrice":0.51,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.261249,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768314600000},"marketStatusCode":1,"adr":0,"adrRate":5,"listingDate":1556078400000,"exchange":"NASDAQ","adjPreClose":0.5673,"preHourTrading":{"tag":"盘前","latestPrice":0.546,"preClose":0.5673,"latestTime":"08:03 EST","volume":209682,"amount":114712.618878,"timestamp":1768309381845},"postHourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5673,"latestTime":"19:59 EST","volume":2473222,"amount":1330001.4139,"timestamp":1768265997745},"volumeRatio":1.5849998380933499,"impliedVol":1.3208,"impliedVolPercentile":0.572},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"2603451686","title":"Mereo BioPharma Group Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2603451686","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603451686?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:04","pubTimestamp":1768305840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MREO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 07:04 ET (12:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2603683429","title":"Mereo Biopharma Group Plc : Needham Cuts Target Price to $3 From $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603683429?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:27","pubTimestamp":1768303622,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","MREO"],"gpt_icon":0},{"id":"2602517046","title":"Mereo BioPharma Extends Cash Runway to Mid-2027 and Updates Setrusumab and Alvelestat Program Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517046","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517046?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222825,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group plc provided a corporate update, highlighting ongoing analyses of data from the Orbit and Cosmic Phase 3 studies of setrusumab  for osteogenesis imperfecta  to determine the potential path forward for the program. The company reported a cash balance of approximately $41 million as of December 31, 2025, and updated its runway guidance to mid-2027 following reductions and delays in pre-commercial and manufacturing activities related to setrusumab. Mereo continues to assess the totality of the Phase 3 trial data and is considering potential interactions with regulators. For its alvelestat  program in alpha-1 antitrypsin deficiency-associated lung disease , Mereo is preparing for a global Phase 3 pivotal study. The anticipated trial will enroll approximately 220 patients and evaluate alvelestat over an 18-month period. The primary efficacy endpoint for U.S. approval is the St. George's Respiratory Questionnaire  Total Score, while lung density measured by CT scan will","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5FcrxK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014039.USD","BK4588","LU2210149790.SGD","SG9999014005.SGD","BK4139","SG9999014013.SGD","SG9999014021.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4505","NDAQ","MREO","LU0314104364.USD","BK4112","BK4585","IE00B64PRP62.GBP","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2601369321","title":"Mereo BioPharma CEO to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369321","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369321?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:14","pubTimestamp":1767874441,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group plc will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 1:30pm PT / 9:30pm GMT. Chief Executive Officer Dr. Denise Scots-Knight will deliver the presentation, and a live audio webcast will be available for those interested in attending virtually.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mereo BioPharma Group plc published the original content used to generate this news brief on January 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL5KkQ0M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2601380208","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2601380208","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601380208?lang=en_us&edition=fundamental","pubTime":"2026-01-08 00:13","pubTimestamp":1767802388,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.51% to 1,719.51 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS  and biopharmaceutical company DBV Technologies , which rose 5.8% and 5.5% respectively. They were followed by telecommunications companies Nokia  and Ericsson , which were up 4.7% and 4% respectively.The decliners from continental Europe were led by consumer goods company Unilever  and oil and gas company Eni , which fell 3.1% and 2.7% respectively. They were followed by lender ING  and semiconductor company Sequans Communications , which were down 1.7% and 0.2% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics  and telecommunications company Vodafone Group , which advanced 4% and 2.3% respectively. They were followed by biopharmaceutical companies Amarin  and Mereo BioPharma Gr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRIB","BK4585","EDAP","BK4082","ERIC","BK4559","SQNS","BK7505","DBVT","BK4592","BK4505","IE00BMPRXN33.USD","AMRN","ING","UN","NOK","IE00BMPRXR70.SGD","BK4132","BK4139","BK4107","BK4142","ULVR.UK","AFG","ING.AU","DEO","BK4020","BK4532","BK4515","UL","BDRX","BK4169","BK4201","DGE.UK","IHG","BK4554","BK4141","BK4207","BK4588","LU0689626769.HKD","BK4117","E","VOD","MREO","BK4591","BK4547","LU0124676726.USD","BK4183","BK7141","BCYC"],"gpt_icon":0},{"id":"2601165819","title":"European Equities Traded in US as ADRs Rise in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2601165819","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601165819?lang=en_us&edition=fundamental","pubTime":"2026-01-07 00:09","pubTimestamp":1767715778,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts rose on Tuesday morning with the S&P Europe Select ADR Index climbing 0.6% to 1,735.19.From continental Europe, the gainers were led by semiconductor contract manufacturing and design company STMicroelectronics  and biopharmaceutical firm DBV Technologies , which rose 6.6% and 4.5% respectively.They were followed by pharmaceutical giant Novo Nordisk , which added 4.4%.The decliners from continental Europe were led by software company SAP  and clinical-stage biotechnology company Abivax , which fell 2.3% and 2.2% respectively.They were followed by financial services company BBVA , which was down 1.3%.From the UK and Ireland, the gainers were led by pharmaceutical and biotech companies GSK  and AstraZeneca , which rose 4.7% and 4.3% respectively.The decliners from the UK and Ireland were led by Mereo BioPharma  and Akari Therapeutics , which dropped nearly 14% and 3.5% respectively.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0006061336.USD","IE00BMPRXR70.SGD","LU0889565916.HKD","BK4139","ABVX","BK4588","BK4613","DBVT","BK4207","SAP","BK4023","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4532","AZN","BK4141","BK4554","BK4568","LU2417539215.USD","LU1093756168.USD","BK7104","MREO","LU2456880835.USD","LU1829250122.USD","BK4599","LU0109394709.USD","NVO","BK4605","BK4528","BK7095","GSK.UK","BK4604","AKTX","IE00BKVL7J92.USD","LU2462157665.USD","BK4007","BBVA","LU0320765992.SGD","GSK","STM","BK4505","IE00BMPRXN33.USD","LU2236285917.USD","BK4585","LU1093756325.SGD"],"gpt_icon":1},{"id":"2600173016","title":"Benzinga Bulls And Bears: Nike, SpaceX, Ultragenyx — And Chinese Tech Stocks Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2600173016","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600173016?lang=en_us&edition=fundamental","pubTime":"2026-01-03 22:01","pubTimestamp":1767448860,"startTime":"0","endTime":"0","summary":"Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/03/Bulls-and-Bears-1.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/03/Bulls-and-Bears-1.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/market-summary/26/01/49680245/benzinga-bulls-and-bears-nike-spacex-ultragenyx-and-chinese-tech-stocks-slide","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49680245/benzinga-bulls-and-bears-nike-spacex-ultragenyx-and-chinese-tech-stocks-slide","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4576","LU0329678170.USD","IE00B775SV38.USD","LU0328353924.USD","LU1366333091.USD","LU0651946864.USD","LU0051755006.USD","LU2125909593.SGD","LU0823397103.USD","LU0345770993.USD","LU0029864427.USD","LU0164865239.USD","LU0079474960.USD","LU0081259029.USD","LU2111349929.HKD","BK4575","LU1435385759.SGD","LU0466842654.USD","SG9999014559.SGD","LU1323610961.USD","LU0889566641.SGD","LU0238689110.USD","CORT","BK4587","BK4548",".IXIC","IE00BYXW3230.USD","LU1934455277.USD","LU0823426480.USD","LU0912757837.SGD","LU1152091168.USD","LU0965509101.SGD","LU0354030438.USD","LU1316542783.SGD","LU2237438978.USD","LU0353189680.USD","LU1261432733.SGD","LU0472753341.HKD","LU0957791311.USD","IE000YTNTUN2.SGD","SG9999015358.SGD","BK4507","LU0140636845.USD","BK4515","LU0787776722.HKD","LU2357125470.USD","IE00BFSS8Q28.SGD","LU2065170008.USD","LU1720050803.USD","LU0795875086.SGD","GB00BDT5M118.USD","LU2237443895.HKD","LU2462157665.USD","LU0650527681.SGD","LU1303224171.USD","LU0314104364.USD","LU0589944569.HKD","LU2237957902.USD","BK4604","IE00BFSS7M15.SGD","LU0109391861.USD","SG9999014575.USD","IE00BQXX3D17.EUR","LU1769817096.USD","LU1623119135.USD","LU0823039010.USD","LU0117841782.USD","RARE","LU0266013472.USD","LU2065171402.SGD","NVDS.UK","SG9999002224.SGD","LU0256863902.USD","LU1951198990.SGD","IE00B1BXHZ80.USD","LU0265550359.USD","LU2125909247.SGD","IE00BYQQ9H92.USD","LU2272731782.SGD","LU1868836591.USD","LU1282648689.USD","SG9999000418.SGD","IE0009356076.USD","IE00B1XK9C88.USD","SG9999001424.SGD","LU1548497426.USD","SG9999014914.USD","LU0823413587.USD","LU1981816686.USD","LU2430703178.SGD","LU2506951792.HKD","LU2148611432.USD","LU0516422440.USD","LU2750360641.GBP","QID","LU1064131342.USD","LU0726765562.USD","LU0861579265.USD","BK4511","LU1244550221.USD","LU1732800096.USD","SG9999014674.SGD","2NVD.UK","BK4573","LU2505996509.AUD","IE0004086264.USD","SNVD.UK","NVDY","NQmain","LU0821914370.USD","LU1084165304.USD","LU1815333072.USD","IE0001KFT4U8.USD","BK4592","SG9999017495.SGD","IE00BJJMRX11.SGD","LU1633808545.USD","IE00BZ1G4Q59.USD","BK4526","LU2039709279.SGD","LU0157215616.USD","IE00B4YYXB79.USD","LU2347655073.USD","IE00BLSP4452.SGD","LU0316494557.USD","LU2077746001.SGD","LU0052750758.USD","LU0823414478.USD","LU0359202008.SGD","LU2286300806.USD","IE00BKPKM429.USD","LU1280957306.USD","LU1934455194.USD","LU0096364046.USD","LU1582987324.SGD","BK4504","LU0072462426.USD","LU0557290698.USD","LU2357305700.SGD","BK4535","IE000KEQY171.SGD","BK4571","LU0823414551.USD","HK0000320264.USD","LU2063271972.USD","LU0528227936.USD","BK4533","LU1923622291.USD","LU0314106906.USD","LU0359201612.USD","LU1571399168.USD","LU0494093205.USD","LU2211817866.USD","IE00B5949003.HKD","LU2237957811.SGD","LU2290526834.HKD","LU1244550577.SGD","BK4099","LU1721428933.USD","SG9999004303.SGD","LU0880133367.SGD","LU0348805143.USD","LU2125909916.SGD","LU1791710582.SGD","LU2347655156.SGD","LU2065169927.USD","SGXZ81514606.USD","LU0348825331.USD","IE00B7SZLL34.SGD","LU0823421416.USD","LU0052756011.USD","LU0708995583.HKD","LU1035775433.USD","IE00BJLML261.HKD","LU0455707207.USD","LU0048584097.USD","NVDU","BK4538","LU0072462343.USD","LU0786609619.USD","LU0203202063.USD","LU1691799644.USD","IE00BGV7N243.SGD","LU1989764748.USD","LU0320764599.SGD","LU0889565833.HKD","LU0463099449.HKD","LU0823434740.USD","LU1868837722.USD","LU2413666426.HKD","LU0737861772.HKD","BK4558","LU1267930730.SGD","LU2097344357.USD","LU2322448957.HKD","LU0310800965.SGD","NVD","LU0158827781.USD","LU0964807845.USD","LU2106854487.HKD","LU2083900584.USD","PSQ","BK4559","LU0128525929.USD","LU1066053197.SGD","LU0234570918.USD","LU2242649171.HKD","LU2360107168.USD","LU0985320562.USD","LU0106959298.USD","UFO","LU0633140727.USD","LU0823426308.USD","SG9999014906.USD","IE00BZ199S13.USD","LU2271345857.HKD","IE0034235303.USD","LU2237443465.HKD","LU1559883803.SGD","LU0871576103.HKD","LU1699723380.USD","LU1206712785.SGD","LU1988902786.USD","BK4139","BK4605","LU2471134879.HKD","LU2213496289.HKD","LU2023251221.USD","LU0661504455.SGD","LU2430703251.USD","HK0000320223.HKD","IE0008368742.USD","LU1720051108.HKD","LU0823434583.USD","LU1839511570.USD","LU1303367103.USD","LU1992135472.HKD","LU1868837300.USD","LU1267930490.SGD","IE00BWXC8680.SGD","IE00BN8TJ469.HKD","LU0154236417.USD","LU0345770308.USD","LU0327786744.USD","IE0002270589.USD","BK4551","BK4607","LU1935043023.USD","SG9999015341.SGD","SG9999018865.SGD","LU2237443622.USD","LU0719512351.SGD","IE00BLSP4239.USD","SG9999014898.SGD","LU0259732245.USD","BK4566","LU2125154935.USD","IE00BD6J9T35.USD","LU0651947912.USD","NVIW.SI","LU1206713676.USD","LU0476273544.USD","LU0868494708.USD","LU0792757196.USD","IE00BMPRXN33.USD","LU2237443549.SGD","LU0516422366.SGD","LU2237443978.SGD","LU1804176565.USD","LU2244417387.USD","BK4550","LU0823421333.USD","SG9999014880.SGD","LU2746668461.USD","3NVD.UK","LU0823038988.USD","LU2463028550.USD","IE00BBT3K403.USD","LU1051768304.USD","LU1188198961.HKD","LU0784383803.USD","LU0077335932.USD","LU2552382215.SGD","IE00BMPRXQ63.HKD","LU2023250504.SGD","LU0516422952.EUR","LU2191332357.HKD","LU2458330243.SGD","BK4007","LU2471134952.CNY","LU1582986359.USD","LU2242644610.SGD","LU0456827905.SGD","LU2361044865.SGD","LU0244354667.USD","BK4585","LU0061474960.USD","LU0289739343.SGD","LU1116320737.USD","LU1868836914.USD","BK4588","NKE","IE00BN29S564.USD","SGXZ23171101.USD","LU2048586759.USD","LU2473716301.USD","IE0004445239.USD","LU1861215975.USD","LU2456880835.USD","LU0353189763.USD","LU0053666078.USD","LU0251132253.USD","LU0149725797.USD","LU0566484027.USD","LU0545039389.USD","LU0979878070.USD","SGXZ31699556.SGD","LU1515016050.SGD","LU0708995401.HKD","LU2592432038.USD","BK4170","BK4524","LU0094547139.USD","BK4503","LU1951200564.SGD","LU1267930227.SGD","LU1171460220.USD","MACW.SI","LU0348816934.USD","LU1291159041.SGD","BK4220","LU2552382132.HKD","LU1582986433.USD","LU0215105999.USD","LU1868836757.USD","LU1808992512.USD","LU1935042488.USD","LU1935042991.SGD","LU0345768153.USD","BK4549","LU0158827948.USD","LU0187121727.USD","LU2023250330.USD","SG9999015978.USD","LU0390134368.USD","LU1496350502.SGD","BK4574","LU1688375341.USD","LU1642822529.SGD","BK4505","LU1629891620.HKD","LU0795875169.SGD","LU2750360997.AUD","LU0082616367.USD","LU2089985449.USD","LU2242650005.HKD","LU2381873111.SGD","BK4579","LU1301847155.USD","LU0307460666.USD","BK4501","MNQmain","IE00B3M56506.USD","LU0251143458.SGD","LU1127390331.HKD","LU0588546209.SGD","LU1235294995.USD","LU2023250843.SGD","LU2461242641.AUD","SG9999014567.USD","BK4532","LU1674673428.USD","LU1803068979.SGD","LU1861558580.USD","LU2602419157.SGD","LU2133065610.SGD","LU0949170772.SGD","LU1105468828.SGD","IE00B19Z3581.USD","LU1770034418.SGD","LU0347712357.USD","BK4122","IE00B19Z9505.USD","LU2505996681.GBP","IE00B19Z8W00.USD","LU2097344431.USD","IE00BQXX3C00.GBP","LU0265550946.USD","LU2430703095.HKD","LU1712237335.SGD","LU1066051225.USD","LU0359201885.HKD","LU2417539215.USD","BK4141","LU0198837287.USD","LU0323591593.USD","LU0594300419.USD","LU0823411888.USD","LU2168564149.EUR","LU2756315664.SGD","LU2272731600.USD","LU1366192091.USD","BK4146","LU2125154778.USD","LU2491050154.USD","BK4565","IE0034235295.USD","LU0203345920.USD","LU0417516902.SGD","LU2361045086.USD","IE00BDRTCR15.USD","LU1989772840.SGD","LU0225283273.USD","LU0057025933.USD","LU0878005551.USD","LU1674673691.USD","LU2433249047.HKD","LU0501845795.SGD","NVD3.UK","IE000W1ABFV2.USD","IE00B29SXG58.USD","LU0724617625.USD","LU1152091754.HKD","LU2177674079.SGD","BK4555","ALBmain","LU2108987350.USD","LU0289960550.SGD","LU1923623000.USD","LU2458330169.SGD","LU0633140560.USD","LU0918141887.USD","LU1323998911.USD","IE00BKDWB100.SGD","LU2931357623.SGD","LU2168564495.EUR","LU2257852520.SGD","LU0315179316.USD","LU0820561818.USD","LU2249611893.SGD","LU0553294199.USD","LU1821325948.USD","LU1551013425.SGD","LU1961090484.USD","LU0672654240.SGD","LU0106261372.USD","LU1868837136.USD","LU1048596156.SGD","BK4509","LU0128525689.USD","IE00B3S45H60.SGD","LU0274383776.USD","LU1051769294.HKD","LU1242518857.USD","BK4614","LU1992135399.USD","IE00BDCRKT87.USD","IE0034224299.USD","LU1861127337.USD","LU2250418816.HKD","LU0345768740.USD","LU0531971595.HKD","LU1232071149.USD","LU1496350171.SGD","BK4531","LU1116320901.HKD","BK4608","SG9999015986.USD","LU0348788117.USD","LU0444973449.USD","HK0000306701.USD","LU0039217434.USD","LU2756315318.SGD","IE00BJTD4V19.USD","LU0820561909.HKD","LU0097036916.USD","USAW.SI","LU1935043536.SGD","LU2168564222.USD","LU0070217475.USD","LU0788109477.HKD","LU2746668974.SGD","LU0784385170.HKD","LU0211328371.USD","LU0561508036.HKD","LU1989764664.SGD","LU2247934214.USD","LU1974910355.USD","LU1066051811.HKD","LU1066051498.USD","HK0000306685.HKD","LU1880383366.USD","LU2226246903.HKD","BK4502","IE00BSNM7G36.USD","IE00BJJMRY28.SGD","LU0797268264.HKD","BK4543","LU0210526637.USD","LU1815336760.USD","IE00BHPRN162.USD","LU0235996351.USD","NVD2.UK","LU2237443382.USD","IE0004091025.USD","LU0234572021.USD","IE0005OL40V9.USD","LU2264538146.SGD","LU0605514214.HKD","LU0820562030.AUD","LU0949170426.SGD","SG9999018857.SGD","LU2008162690.USD","BK4534","LU1718418525.SGD","LU0310799852.SGD","LU2028103732.USD","LU0456855351.SGD","LU2087625088.SGD","LU2098885051.SGD","LU0342679015.USD","LU1868837565.USD","LU2360032135.SGD","BK4612","BK4598","LU1267930573.SGD","LU0048580855.USD","QLD","LU2413666699.HKD","IE00BK4W5L77.USD","BK4527","LU2054465674.USD","LU0109392836.USD","LU0056508442.USD","LU2168564065.EUR","SG9999002562.SGD","LU1917777945.USD","LU0345769631.USD","IE00B775H168.HKD","LU0049112450.USD","LU0823413660.USD","LU0738911758.USD","LU0511384066.AUD","LU0210533765.USD","SG9999002232.USD","LU2361044949.HKD","LU0096362180.USD","LU0943347566.SGD","LU0348723411.USD","SQQQ","LU2896262040.SGD","LU1719994722.HKD","LU0276348264.USD","LU0882574139.USD","SG9999014542.SGD","LU2399975544.HKD","LU0348827113.USD","LU1119994496.HKD","LU2452424414.USD","LU0320765059.SGD","LU0965508806.USD","LU1861220033.SGD","USJW.SI","LU0211327993.USD","LU1861559042.SGD","LU0689472784.USD","BK4561","NVDX","LU0210536198.USD","LU0107464264.USD","LU0683600562.USD","LU2471134796.USD","LU1037948897.HKD","LU2326559502.SGD","LU2265009873.SGD","LU1003077747.HKD","LU1242518931.SGD","LU1720051017.SGD","IE0034235188.USD","LU0370786039.SGD","BK4554","LU0143863198.USD","LU0256863811.USD","LU1880383440.USD","LU2092627202.USD","IE00B0JY6N72.USD","LU0310800379.SGD","LU2491050071.SGD","LU1008478684.HKD","LU2322448791.USD","LU1935042215.USD","LU0572944931.SGD","LU0203201768.USD","LU2860962120.EUR","LU0143863784.USD","LU0965509010.AUD","IE00B7KXQ091.USD","LU0329678337.USD","LU1794554557.SGD","LU2089283258.USD","LU0516423091.SGD","LU2420271590.USD","LU1048588211.SGD","TSYW.SI","LU1868838027.USD","LU2360106780.USD","LU2552382058.USD","LU0061475181.USD","IE00BF5LJ272.USD","LU0642271901.SGD","LU1037948541.HKD","LU0231483743.USD","LU0210528500.USD","NVDD","LU0784384876.USD","LU1551013342.USD","IE00BFMHRM44.USD","LU2272731865.HKD","LU0708994859.HKD","LU2065171311.SGD","LU0417517546.SGD","BK4516","LU0918141705.HKD","LU0289961442.SGD","LU1046421795.USD","LU0965509283.SGD","LU0957808578.USD","IE00B19Z3B42.SGD","LU1582987597.SGD","LU1506573853.SGD","LU1778281490.HKD","IE00BK4W5M84.HKD","LU0124676726.USD","LU0069063385.USD","LU1989772923.USD","LU1732799900.SGD","LU2211815571.USD","IE00B19Z8X17.USD","IE0003U64NQ7.SGD","LU1934455863.HKD","LU0080751232.USD","LU0047713382.USD","IE00BQXX3F31.USD","LU0784385840.USD","LU0170899867.USD","IE0009G5SDU7.USD","IE00BKVL7J92.USD","LU0308772762.SGD","SG9999002828.SGD","LU0354030511.USD","LU0067412154.USD","BK4581","LU0594300179.USD","LU1145028129.USD","LU2089284900.SGD","LU1429558221.USD","NVDS","LU0516423174.USD","IE000ITXATA3.USD","LU0006306889.USD","LU0683595622.HKD","IE00BMPRXR70.SGD","LU1267930813.SGD","LU1814569148.SGD","LU1914381329.SGD","BK4553","LU0868494617.USD","LU0942090050.USD","LU0502904849.HKD","SG9999002463.SGD","LU2491049909.HKD","LU1769817179.HKD","SG9999015952.SGD","LU2168563687.JPY","LU2294711713.HKD","LU2092937148.SGD","LU2087589342.USD","IE0004445015.USD","LU1069344957.HKD","LU1791710400.SGD","LU0061474705.USD","LU1923622614.USD","LU1023057109.AUD","LU0267386448.USD","TQQQ","LU0456846285.SGD","LU0348814723.USD","LU2543165471.USD","LU2487616109.SGD","BK4567","LU0640476718.USD","LU0127658192.USD","IE00BFXG0V08.USD","LU1852331112.SGD","LU0823397285.USD","MREO","LU0011850046.USD","LU1956131251.USD","LU1823568750.SGD","LU1983260115.SGD","LU2403377893.USD","BK4529","SG9999015945.SGD","LU2125909759.SGD","LU2471134523.USD","LU2236285917.USD","LU0689626769.HKD","LU1244550494.USD","LU0175139822.USD","LU0345769128.USD","IE00B3SWFQ91.USD","BK4512","LU0326950275.SGD","SGXZ99366536.SGD","LU2087621335.USD","SGXZ51526630.SGD","LU1235295612.USD","LU0203347892.USD","IE00BJTD4N35.SGD","LU0072913022.USD","LU1251922891.USD","IE00B4JS1V06.HKD","LU1989771016.USD","LU1046422090.SGD","LU0444971666.USD"],"gpt_icon":1},{"id":"2600619230","title":"European Equities Traded in the US as American Depositary Receipts Gain Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2600619230","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600619230?lang=en_us&edition=fundamental","pubTime":"2026-01-03 00:09","pubTimestamp":1767370173,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Friday morning, up 1.6% to 1,704.80 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor companies ASML , STMicroelectronics , and Sequans Communications , which rose 9.3%, 6.3% and 6.2%, respectively.They were followed by pharmaceutical giant Novo Nordisk , which was up 2.2%.The decliners from continental Europe were led by clinical-stage immuno-oncology company Genenta Science  and advertising company Criteo , which fell 6% and 2.7%, respectively.They were followed by software company SAP , which was down 2.5%.From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma  and semiconductor company Arm , which rose nearly 9% and 4.5%, respectively.The decliners from the UK and Ireland were led by commercial-stage biotechnology company Trinity Biotech  and educational publishing company Pearson , which shed 6% and 2.5% respectively.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ1G4Q59.USD","IE00BMPRXR70.SGD","BK4532","IE0004445239.USD","03165","BK4117","SAP","IE00BMPRXQ63.HKD","BK4204","BK4023","GNTA","BK4528","IE00BFMHRM44.USD","LU0823434583.USD","LU1734074674.USD","BK4613","IE00BKVL7J92.USD","BK4604","BK4007","BK4609","LU1093756168.USD","ARM","LU0345774631.USD","LU2063271972.USD","LU0154236417.USD","PSO","BK4139","LU1093756325.SGD","BK4107","BK7095","LU2543165471.USD","BK7104","TRIB","LU0348723411.USD","BK4505","LU0823434740.USD","IE00BD6J9T35.USD","BK4009","BK4599","CRTO","BK4605","BK4543","BK4111","ASML","BK4147","MREO","BK4588","BK4585","LU0345774391.USD","BK4141","BK4554","LU0006061336.USD","LU0097036916.USD","IE00BMPRXN33.USD","STM","SQNS","BK4082","LU0081259029.USD"],"gpt_icon":1},{"id":"1108335380","title":"Wall Street's Top Analysts Latest Ratings: DigitalBridge Downgraded","url":"https://stock-news.laohu8.com/highlight/detail?id=1108335380","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108335380?lang=en_us&edition=fundamental","pubTime":"2025-12-31 00:10","pubTimestamp":1767111043,"startTime":"0","endTime":"0","summary":"Here is a summary of the most discussed and market-moving analyst research report ratings from Wall Street. The following are the day's latest key rating changes compiled by The Fly that investors...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a9c5b2ea6477641c148f3bfa413b9f24","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0300736062.USD","ERO","LU2125909916.SGD","LU2065731478.USD","CVLT","BK4168","BK4182","BK4532","LU2065169927.USD","BK4588","BK4135","LU2065171402.SGD","BK4613","LU1923622291.USD","NKLR","LU2286300806.USD","LU2125909759.SGD","BK4233","MREO","BK4097","BK4585","DBRG","IE00BLDYK493.USD","BK4505","LU0054578231.USD","LU0963586101.USD","LU2065170008.USD","LU0300736492.USD","BK4160","BK4205","VRNS","BHP","BK4139","LU0274383776.USD","IE00B64QTZ34.USD","LU2065171311.SGD","BK4015","RARE","RBRK"],"gpt_icon":0},{"id":"2595371673","title":"This Mereo BioPharma Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2595371673","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595371673?lang=en_us&edition=fundamental","pubTime":"2025-12-30 23:48","pubTimestamp":1767109680,"startTime":"0","endTime":"0","summary":"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/30/Analyst-Works-On-Personal-Computer-Showi.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/30/Analyst-Works-On-Personal-Computer-Showi.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/25/12/49631794/this-mereo-biopharma-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-tuesday","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/25/12/49631794/this-mereo-biopharma-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4112","MREO"],"gpt_icon":0},{"id":"2595794457","title":"Jefferies Downgrades Mereo BioPharma to Hold From Buy, Adjusts Price Target to $0.50 From $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2595794457","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595794457?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:11","pubTimestamp":1767096715,"startTime":"0","endTime":"0","summary":"Mereo BioPharma (MREO) has an average rating of overweight and mean price target of $4.39, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2595765847","title":"Mereo Biopharma Group Plc : Leerink Partners Cuts Target Price to $2 From $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2595765847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595765847?lang=en_us&edition=fundamental","pubTime":"2025-12-30 12:09","pubTimestamp":1767067777,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3XY01I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2595737851","title":"Mereo BioPharma Group Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2595737851","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595737851?lang=en_us&edition=fundamental","pubTime":"2025-12-30 02:34","pubTimestamp":1767033240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MREO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 29, 2025 13:34 ET (18:34 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2595327937","title":"LifeSci Capital Downgrades Mereo BioPharma Group to Market Perform From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2595327937","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595327937?lang=en_us&edition=fundamental","pubTime":"2025-12-30 02:28","pubTimestamp":1767032886,"startTime":"0","endTime":"0","summary":"Price: 0.25, Change: -2.06, Percent Change: -89.00","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2595329737","title":"These biotech stocks are getting hammered by shocking brittle-bone treatment study results","url":"https://stock-news.laohu8.com/highlight/detail?id=2595329737","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595329737?lang=en_us&edition=fundamental","pubTime":"2025-12-30 02:05","pubTimestamp":1767031500,"startTime":"0","endTime":"0","summary":"Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab. Shares of Ultragenyx and Mereo BioPharma were rocked by disappointing late-stage trial results of their brittle-bone disease treatment.It's looking like a poor end to 2025 for investors in two biotechnology companies that on Monday reported surprisingly disappointing trial results for a treatment for a rare bone disease.Shares of both Ultragenyx Pharmaceutical  and Mereo BioPharma Group  were suffering record one-day selloffs and heading toward record lows as the biggest losers on the New York Stock Exchange.The two biotechs are partners, as they are collaborating in the development of setrusumab for the treatment of osteogenesis imperfecta - a rare genetic bone metabolism disorder known as brittle-bone disease.\"We are surprised and disappointed by these results given the promising data from our Phase 2 study and the lack of approved treatment options available to","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2595731172","title":"Top Midday Stories: DigitalBridge to Be Acquired by SoftBank; Ultragenyx's Brittle Bone Disease Drug Studies Miss Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2595731172","media":"MT Newswires Live","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595731172?lang=en_us&edition=fundamental","pubTime":"2025-12-30 00:26","pubTimestamp":1767025581,"startTime":"0","endTime":"0","summary":"All three major US stock indexes were down in late-morning trading Monday to kick off the final few trading days of the year.In company news, DigitalBridge (Group DBRG) has agreed to be acquired by So","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ef8b8046ea47217c7fdadbf730cff3d3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4156","BK4505","BK4585","BK4606","BK4122","LU0823411888.USD","BK4504","LU1242518857.USD","BK4132","BK4135","BK4160","DBRG","LU1496350502.SGD","BK4205","03160","BK4220","BK4202","RARE","BK4233","MREO","BK4139","LU0979878070.USD","BK4588","LU1242518931.SGD"],"gpt_icon":0},{"id":"2595173932","title":"Ultragenyx-Mereo Bone Drug Trial Disappoints, Stocks Hit 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2595173932","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595173932?lang=en_us&edition=fundamental","pubTime":"2025-12-29 23:15","pubTimestamp":1767021300,"startTime":"0","endTime":"0","summary":"Ultragenyx and Mereo BioPharma hit 52-week low after disappointing results from Phase 3 studies for Osteogenesis Imperfecta treatment.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/29/Market--Down--Creative-Crash-Recession-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/29/Market--Down--Creative-Crash-Recession-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49611215/ultragenyx-mereo-bone-drug-trial-disappoints-stocks-hit-52-week-lows","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49611215/ultragenyx-mereo-bone-drug-trial-disappoints-stocks-hit-52-week-lows","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4126","BK4139","MREO","BK4505","OI","RARE"],"gpt_icon":0},{"id":"2595673614","title":"Update: Ultragenyx Shares Fall After Brittle Bone Disease Studies Fail to Achieve Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673614","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595673614?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:57","pubTimestamp":1767020258,"startTime":"0","endTime":"0","summary":"(Updates with recent stock price movement in the headline and first paragraph, and adding information on partnership with Mereo in the fifth paragraph.)Ultragenyx Pharmaceutical's (RARE) shares fell m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3582e8b9661b08b591794cc3daf7054b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4139","MREO","RARE"],"gpt_icon":0},{"id":"2595735508","title":"Mereo BioPharma, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Monday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2595735508","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595735508?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:17","pubTimestamp":1767017820,"startTime":"0","endTime":"0","summary":"U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday.Shares of Mereo BioPharma Group plc – ADR  fell sharply in pre-market trading after the company announced its Phase 3 ORBIT and COSMIC Studies for setrusumab in Osteogenesis Imperfecta did not achieved statistical significance against the primary endpoints of reduction in annualized clinical fracture rate compared to placebo or bisphosphonates, respectively.Mereo BioPharma Group shares tumbled 87.5% to $0.29in pre-market trading.Here are some other stocks moving lower in pre-market trading.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/29/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/29/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/12/49608882/mereo-biopharma-ultragenyx-pharmaceutical-and-other-big-stocks-moving-lower-in-mondays-pre-market-session","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/12/49608882/mereo-biopharma-ultragenyx-pharmaceutical-and-other-big-stocks-moving-lower-in-mondays-pre-market-session","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["RARE","BK4505","MREO","BK4139"],"gpt_icon":0},{"id":"2595673874","title":"Mereo BioPharma Shares Halted, Pending Material News Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673874","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595673874?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:39","pubTimestamp":1767015566,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Shares Halted, Pending Material News Release","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":0.1804},{"period":"1month","weight":-0.7386},{"period":"3month","weight":-0.7106},{"period":"6month","weight":-0.6758},{"period":"1year","weight":-0.8402},{"period":"ytd","weight":0.3614}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.028605},{"month":2,"riseRate":0.5,"avgChangeRate":0.038485},{"month":3,"riseRate":0,"avgChangeRate":-0.177922},{"month":4,"riseRate":0.666667,"avgChangeRate":0.141069},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.12077},{"month":6,"riseRate":0.714286,"avgChangeRate":0.399821},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.055261},{"month":8,"riseRate":0.857143,"avgChangeRate":0.105012},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100596},{"month":10,"riseRate":0.428571,"avgChangeRate":0.068788},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.101401},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001557}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}